Addex

Allosteric modulators for human health

  • About us
    • Overview
    • Addex Corporate Presentation
    • Our people
      • Executive Officers
      • Non-Executive Directors
      • Scientific Advisory Board
    • Contact
    • Privacy Policy
  • Pipeline
    • Research And Development
    • Clinical and Pre-Clinical Pipeline
    • Publications
  • Technology platform
    • Allosteric modulation
    • Our capabilities
      • Screening Assays
      • Chemistry
  • Partners & collaboration
  • Investors
    • Stock Data
    • Downloads
    • Register for email news
    • Corporate Governance
    • SEC Filings
  • News Events & Careers
    • Press releases
    • Events
    • Careers
about us

about us

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

Pipeline

Clinical and Pre-Clinical Pipeline Publications
  • Dipraglurant-IR for PD-LID
  • Dipraglurant-ER for dystonia
  • ADX71149 for epilepsy
  • GABAB PAM for addiction
  • GABAB PAM for CMT1A
  • mGlu7 NAM for PTSD
  • mGlu2 NAM for mild neurocognitive disorders
  • mGlu4 PAM for Parkinson’s disease
  • mGlu3 PAM for neurodegenerative disorders
Placeholder image

Technology platform

Allosteric Modulation

Read more
Placeholder image

Partners & Collaborations

Industry

Read more

Latest news Latest news icon

  • 01.12
    2021

    Addex to Present at the Baader Helvea Swiss Equities Conference

  • 01.11
    2021

    Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities

  • 01.07
    2021

    Addex Announces Pricing of $10.0 Million Global Offering

  • 12.14
    2020

    Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities

  • 11.03
    2020

    Addex Reports Q3 2020 Financial Results and Provides Corporate Update

Contact us

If you have any questions please let me know
  • Contact form
2021 © Addex therapeutics